首页> 外国专利> Sustained Release composition comprising a Peptide; Process for preparing the composition; prophylactic or therapeutic agent for Cancer of Prostate, prostatic hyperplasiaEndometriosis, uterine fibroid, uterine fibroids, puberty

Sustained Release composition comprising a Peptide; Process for preparing the composition; prophylactic or therapeutic agent for Cancer of Prostate, prostatic hyperplasiaEndometriosis, uterine fibroid, uterine fibroids, puberty

机译:包含肽的持续释放组合物;制备组合物的方法;前列腺癌,前列腺增生的预防或治疗剂子宫内膜异位,子宫肌瘤,子宫肌瘤,青春期

摘要

Sustained-release compositions wherein a water-soluble physiologically active peptide is substantially uniformly dispersed in a microcapsule comprised of a lactic acid polymer or a salt thereof, and the physiologically active substance is contained in an amount of 15 to 35 wt/wt % to the total microcapsules and weight-average molecular weight (Mw) of the lactic acid polymer is about 11,000 to about 27,000, which is characterized by having a high content of the physiologically active substance, and suppression of the initial excessive release within one day after the administration and a stable drug sustained-release over a long period of time, and method for producing the same.
机译:缓释组合物,其中水溶性生理活性肽基本上均匀地分散在由乳酸聚合物或其盐组成的微胶囊中,并且生理活性物质的含量相对于所述缓释组合物为15-35wt / wt%。乳酸聚合物的总微胶囊和重均分子量(Mw)为约11,000至约27,000,其特征在于具有高的生理活性物质含量,并且在给药后一天之内抑制了最初的过度释放。以及长期稳定释放的药物及其制备方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号